Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects

Abotaleb, 2019, Flavonoids in cancer and apoptosis, Cancers (Basel)., 11, 28, 10.3390/cancers11010028

Abuelsaad, 2013, Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic Aeromonas hydrophila in a murine model, Life Sci., 93, 714, 10.1016/j.lfs.2013.09.019

Agarwal, 2016, Is cancer chemotherapy dying? Asian, J. Transfus. Sci., 10, S1, 10.4103/0973-6247.182735

Agrawal, 2014, Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats, PLoS ONE, 9, e111212, 10.1371/journal.pone.0111212

Akiyama, 2009, Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats, J. Clin. Biochem. Nutr., 46, 87, 10.3164/jcbn.09-82

Al-Rikabi, 2020, In vivo and in vitro evaluation of the protective effects of hesperidin in lipopolysaccharide-induced inflammation and cytotoxicity of cell, Molecules, 25, 478, 10.3390/molecules25030478

Ali, 2016, Molecular mechanisms and mode of tamoxifen resistance in breast cancer, Bioinformation, 12, 135, 10.6026/97320630012135

Amin, 2008, Chemopreventive effect of chlorella on the antioxidant system in 7, 12-dimethylbenz[a]anthracene-induced oxidative stress in liver, Int. J. Pharmacol., 4, 169, 10.3923/ijp.2008.169.176

Atanasov, 2021, Natural products in drug discovery: advances and opportunities, Nat. Rev. Drug Discov., 20, 200, 10.1038/s41573-020-00114-z

Atwal, 2019, Intercalating TOP2 poisons attenuate topoisomerase action at higher concentrations, Mol. Pharmacol., 96, 475, 10.1124/mol.119.117259

Borland, 2009, Activation of protein kinase Calpha by EPAC1 is required for the ERK- and CCAAT/enhancer-binding protein beta-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cells, J. Biol. Chem., 284, 17391, 10.1074/jbc.M109.015370

Bracken, 2009, Why animal studies are often poor predictors of human reactions to exposure, J. R. Soc. Med., 102, 120, 10.1258/jrsm.2008.08k033

Brand, 2010, The effect of co-administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco-2 cell monolayers, Mol. Nutr. Food Res., 54, 851, 10.1002/mnfr.200900183

Brand, 2008, Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers, Drug Metab. Dispos., 36, 1794, 10.1124/dmd.107.019943

Bredsdorff, 2010, Absorption, conjugation and excretion of the flavanones, naringenin and hesperetin from alpha-rhamnosidase-treated orange juice in human subjects, Br. J. Nutr., 103, 1602, 10.1017/S0007114509993679

Browne, 2009, HER-2 signaling and inhibition in breast cancer, Curr. Cancer Drug Targets, 9, 419, 10.2174/156800909788166484

Cabeza, 2015, Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles, Int. J. Nanomedicine, 10, 1291

Castro-Giner, 2020, Tracking cancer progression: from circulating tumor cells to metastasis, Genome Med., 12, 31, 10.1186/s13073-020-00728-3

Cervantes, 1988, The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells, Cancer Lett., 41, 169, 10.1016/0304-3835(88)90113-9

Cha, 2019, Mechanisms controlling PD-L1 expression in cancer, Mol. Cell, 76, 359, 10.1016/j.molcel.2019.09.030

Chandrika, 2016, Hesperetin and naringenin sensitize HER2 positive cancer cells to death by serving as HER2 tyrosine kinase inhibitors, Life Sci., 160, 47, 10.1016/j.lfs.2016.07.007

Chew, 2001, Adjuvant therapy for breast cancer: who should get what?, West. J. Med., 174, 284, 10.1136/ewjm.174.4.284

Choi, 2007, Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21, Nutr. Cancer, 59, 115, 10.1080/01635580701419030

Chow, 2014, Bioavailability and bioequivalence in drug development, Wiley Interdiscip. Rev. Comput. Stat., 6, 304, 10.1002/wics.1310

Chumsri, 2015, Clinical utilities of aromatase inhibitors in breast cancer, Int. J. Womens Health, 7, 493, 10.2147/IJWH.S69907

Coldwell, 2008, Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations, Nucleic Acids Res., 36, 10.1093/nar/gkn439

Colone, 2020, Drug delivery systems of natural products in oncology, Molecules, 25, 4560, 10.3390/molecules25194560

Cragg, 2016, Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents, Med. Princ. Pract., 25, 41, 10.1159/000443404

Criscitiello, 2011, Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection, Onco. Targets. Ther., 4, 1

Dai, 2015, Breast cancer intrinsic subtype classification, clinical use and future trends, Am. J. Cancer Res., 5, 2929

Del Mar Contreras, 2016, Further exploring the absorption and enterocyte metabolism of quercetin forms in the Caco-2 model using nano-LC-TOF-MS, Electrophoresis, 37, 998, 10.1002/elps.201500375

Dhanya, 2020, In vitro evaluation of antidiabetic potential of hesperidin and its aglycone hesperetin under oxidative stress in skeletal muscle cell line, Cell Biochem. Funct., 38, 419, 10.1002/cbf.3478

Dutta, 2019, Natural products: An upcoming therapeutic approach to cancer, Food Chem. Toxicol., 128, 240, 10.1016/j.fct.2019.04.012

Economopoulou, 2012, The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies, Oncologist, 17, 1394, 10.1634/theoncologist.2012-0163

El‐Sisi, 2020, Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity, Fundam. Clin. Pharmacol., 34, 458, 10.1111/fcp.12549

Ferreira de Oliveira, 2020, Therapeutic potential of hesperidin and its aglycone hesperetin: Cell cycle regulation and apoptosis induction in cancer models, Phytomedicine, 73, 152887, 10.1016/j.phymed.2019.152887

Gaber, 2019, Boronic-targeted albumin-shell oily-core nanocapsules for synergistic aromatase inhibitor/herbal breast cancer therapy, Mater. Sci. Eng. C Mater. Biol. Appl., 105, 110099, 10.1016/j.msec.2019.110099

García-Pinel, 2019, Lipid-based nanoparticles: Application and recent advances in cancer treatment, Nanomaterials, 9, 638, 10.3390/nano9040638

Gasco, 2002, The p53 pathway in breast cancer, Breast Cancer Res., 4, 70, 10.1186/bcr426

Gigliobianco, 2018, Nanocrystals of poorly soluble drugs: Drug bioavailability and physicochemical stability, Pharmaceutics, 10, 134, 10.3390/pharmaceutics10030134

Gu, 2018, Effects of miR-21 on proliferation and apoptosis in human gastric adenocarcinoma cells, Oncol. Lett., 15, 618

Haque, 2019, Pathways to endocrine therapy resistance in breast cancer, Front. Endocrinol. Lausanne, 10, 573, 10.3389/fendo.2019.00573

Hardigree, 1978, Comparative mutagenesis of plant flavonoids in microbial systems, Mutat. Res., 58, 231, 10.1016/0165-1218(78)90014-9

He, 2016, Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective, Onco. Targets Ther., 9, 1077

He, 2019, Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/d-galactosamine induced acute liver failure in mice, Int. Immunopharmacol., 68, 171, 10.1016/j.intimp.2018.12.059

Heery, 2018, Precautions for patients taking tamoxifen, J. Adv. Pract. Oncol., 9

Hermawan, 2021, Identification of key genes of hesperidin in inhibition of breast cancer stem cells by functional network analysis, Comput. Biol. Chem., 90, 107427, 10.1016/j.compbiolchem.2020.107427

Hume, 2020, A unified model for the G1/S cell cycle transition, Nucleic Acids Res., 48, 12483, 10.1093/nar/gkaa1002

Israel, 2018, Phytochemicals: current strategies for treating breast cancer, Oncol. Lett., 15, 7471

Ji, 2019, Chemoresistance mechanisms of breast cancer and their countermeasures, Biomed. Pharmacother., 114, 108800, 10.1016/j.biopha.2019.108800

Jiang, 2016, Modifications of the method for calculating absolute drug bioavailability, J. Pharm. Pharm. Sci., 19, 181, 10.18433/J3RG78

Jiao, 2020, Metabolism study of hesperetin and hesperidin in rats by UHPLC-LTQ-Orbitrap MSn, Xenobiotica, 50, 1311, 10.1080/00498254.2019.1567956

Kabała-Dzik, 2018, Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7 - a comparative study, Cell. Mol. Biol., 64, 1, 10.14715/cmb/2018.64.8.1

Kalyanaraman, 2020, Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?, Redox Biol., 29, 101394, 10.1016/j.redox.2019.101394

Kapinova, 2018, Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention, Environ. Health Prev. Med., 23, 36, 10.1186/s12199-018-0724-1

Kawaguchi, 1997, Hesperidin as an inhibitor of lipases from porcine pancreas and Pseudomonas, Biosci. Biotechnol. Biochem., 61, 102, 10.1271/bbb.61.102

Khamis, 2018, Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells, Biomed. Pharmacother., 105, 1335, 10.1016/j.biopha.2018.06.105

Kianfar, 2021, Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles, J. Nanobiotechnology, 19, 159, 10.1186/s12951-021-00896-3

Klimp, 2002, A potential role of macrophage activation in the treatment of cancer, Crit. Rev. Oncol. Hematol., 44, 143, 10.1016/S1040-8428(01)00203-7

Kongtawelert, 2020, Inhibitory effect of hesperidin on the expression of programmed death ligand (PD-L1) in breast cancer, Molecules, 25, 252, 10.3390/molecules25020252

Korga-Plewko, 2020, Apigenin and hesperidin downregulate dna repair genes in MCF-7 breast cancer cells and augment doxorubicin toxicity, Molecules, 25, 4421, 10.3390/molecules25194421

Lee, 2010, Hesperidin suppressed proliferations of both human breast cancer and androgen-dependent prostate cancer cells, Phyther. Res., 24, S15

Li, 2017, Health-promoting effects of the citrus flavanone hesperidin, Crit. Rev. Food Sci. Nutr., 57, 613, 10.1080/10408398.2014.906382

Li, 2013, The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer, J. Nutr. Biochem., 24, 1112, 10.1016/j.jnutbio.2012.08.010

Li, 2011, Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7, Mol. Cell. Endocrinol., 344, 51, 10.1016/j.mce.2011.06.024

Li, 2017, The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis, Oncol. Lett., 14, 5865

Li, 2017, Tamoxifen promotes apoptosis and inhibits invasion in estrogen-positive breast cancer MCF-7 cells, Mol. Med. Rep., 16, 478, 10.3892/mmr.2017.6603

Li, 2019, Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in Sprague Dawley rats, Regul. Toxicol. Pharm., 105, 77, 10.1016/j.yrtph.2019.04.001

Li, 2008, In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts, J. Agric. Food Chem., 56, 5550, 10.1021/jf800105c

Lin, 2014, Downregulation of Bcl-2 expression by miR-34a mediates palmitate-induced Min6 cells apoptosis, J. Diabetes Res., 2014, 1

Lin, 2020, Glucose metabolism on tumor plasticity, diagnosis, and treatment, Front. Oncol., 10, 317, 10.3389/fonc.2020.00317

Liyanage, 2019, Nanoparticle-mediated targeted drug delivery for breast cancer treatment, Biochim. Biophys. Acta - Rev. Cancer, 1871, 419, 10.1016/j.bbcan.2019.04.006

Long, 2018, Lipid metabolism and carcinogenesis, cancer development, Am. J. Cancer Res., 8, 778

Lumachi, 2013, Treatment of estrogen receptor-positive breast cancer, Curr. Med. Chem., 20, 596, 10.2174/092986713804999303

Lüönd, 2021, Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression, Br. J. Cancer, 125, 164, 10.1038/s41416-021-01328-7

Magura, 2020, The effect of hesperidin and luteolin isolated from Eriocephalus africanus on apoptosis, cell cycle and miRNA expression in MCF-7, J. Biomol. Struct. Dyn., 1

Mahmoud, 2019, Beneficial effects of citrus flavonoids on cardiovascular and metabolic health, Oxid. Med. Cell. Longev., 2019, 1

Mahon, 2003, MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models, Blood, 101, 2368, 10.1182/blood.V101.6.2368

Mas-Capdevila, 2020, Effect of hesperidin on cardiovascular disease risk factors: the role of intestinal microbiota on hesperidin bioavailability, Nutrients, 12, 1488, 10.3390/nu12051488

Mehanna, 2019, Triple-negative breast cancer: current perspective on the evolving therapeutic landscape, Int. J. Womens Health, 11, 431, 10.2147/IJWH.S178349

Micalizzi, 2017, A conduit to metastasis: circulating tumor cell biology, Genes Dev., 31, 1827, 10.1101/gad.305805.117

Miller, 2003, Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer, Semin. Oncol., 30, 3, 10.1016/S0093-7754(03)00302-6

Mitchell, 2021, Engineering precision nanoparticles for drug delivery, Nat. Rev. Drug Discov., 20, 101, 10.1038/s41573-020-0090-8

Momenimovahed, 2019, Epidemiological characteristics of and risk factors for breast cancer in the world, Breast Cancer Targets Ther., 11, 151, 10.2147/BCTT.S176070

Moon, 2013, Antimicrobial effect of 7-O-butylnaringenin, a novel flavonoid, and various natural flavonoids against Helicobacter pylori strains, Int. J. Environ. Res. Public Health, 10, 5459, 10.3390/ijerph10115459

Nandakumar, 2014, Modulating effects of hesperidin on key carbohydrate-metabolizing enzymes, lipid profile, and membrane-bound adenosine triphosphatases against 7,12-dimethylbenz(a)anthracene-induced breast carcinogenesis, Hum. Exp. Toxicol., 33, 504, 10.1177/0960327113485252

Noman, 2017, The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200, Oncoimmunology, 6, e1263412, 10.1080/2162402X.2016.1263412

Nounou, 2015, Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies, Breast Cancer Targets Ther., 9, 17

Nurhayati, 2020, Cytotoxic and antimetastatic activity of hesperetin and doxorubicin combination toward Her2 expressing breast cancer cells, Asian Pacific J. Cancer Prev., 21, 1259, 10.31557/APJCP.2020.21.5.1259

Organisation for Economic Co-operation and Development, 2001. OECD Guideline for Testing of Chemicals [WWW Document]. URL https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd_gl423.pdf (accessed 4.17.21).

Ortiz-Andrade, 2020, Toxicological screening of four bioactive citroflavonoids: in vitro, in vivo, and in silico approaches, Molecules, 25, 5959, 10.3390/molecules25245959

Palit, 2015, Hesperetin induces apoptosis in breast carcinoma by triggering accumulation of ROS and activation of ASK1/JNK pathway, J. Cell. Physiol., 230, 1729, 10.1002/jcp.24818

Pang, 2013, Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin, Nat. Commun., 4, 1908, 10.1038/ncomms2921

Pang, 2021, Effects of dietary patterns combined with dietary phytochemicals on breast cancer metastasis, Life Sci., 264, 118720, 10.1016/j.lfs.2020.118720

Parhiz, 2015, Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models, Phyther. Res., 29, 323, 10.1002/ptr.5256

Patra, 2018, Nano based drug delivery systems: recent developments and future prospects, J. Nanobiotechnology, 16, 71, 10.1186/s12951-018-0392-8

Pekarsky, 2018, BCL2 and miR-15/16: from gene discovery to treatment, Cell Death Differ., 25, 21, 10.1038/cdd.2017.159

Pfeuty, 2012, Strategic cell-cycle regulatory features that provide mammalian cells with tunable G1 length and reversible G1 arrest, PLoS ONE, 7, e35291, 10.1371/journal.pone.0035291

Pizzimenti, 2010, The “two-faced” effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer, Cancers (Basel)., 2, 338, 10.3390/cancers2020338

Pulido, 2017, Bone metastasis risk factors in breast cancer, Ecancermedicalscience, 11, 715, 10.3332/ecancer.2017.715

Purushothaman, 2020, Magnetic casein-CaFe2O4 nanohybrid carrier conjugated with progesterone for enhanced cytotoxicity of citrus peel derived hesperidin drug towards breast and ovarian cancer, Int. J. Biol. Macromol., 151, 293, 10.1016/j.ijbiomac.2020.02.172

Racay, 1997, Lipid peroxidation both inhibits Ca(2+)-ATPase and increases Ca2+ permeability of endoplasmic reticulum membrane, IUBMB Life, 41, 647, 10.1080/15216549700201691

Rachner, 2020, Challenges in preventing bone loss induced by aromatase inhibitors, J. Clin. Endocrinol. Metab., 105, 3122, 10.1210/clinem/dgaa463

Rahideh, 2017, The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of aromatase in breast cancer cells, Cell. Mol. Biol., 63, 9, 10.14715/cmb/2017.63.2.2

Rahideh, 2016, The individual or combinational effects of Hesperetin and Letrozole on the activity and expression of aromatase in MCF-7 cells, Cell. Mol. Biol., 62, 38

Rahman, 2021, Phytochemicals as a complement to cancer chemotherapy: Pharmacological modulation of the autophagy-apoptosis pathway, Front. Pharmacol., 12, 10.3389/fphar.2021.639628

Raman, 2020, Editorial: the role of breast cancer stem cells in clinical outcomes, Front. Oncol., 10, 299, 10.3389/fonc.2020.00299

Rath, 2009, De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma, Int. J. Biochem. Cell Biol., 41, 1165, 10.1016/j.biocel.2008.10.021

Rauchová, 1995, The effect of lipid peroxidation on the activity of various membrane-bound ATPases in rat kidney, Int. J. Biochem. Cell Biol., 27, 251, 10.1016/1357-2725(94)00083-N

Rexer, 2012, Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications, Crit. Rev. Oncog., 17, 1, 10.1615/CritRevOncog.v17.i1.20

Roohbakhsh, 2014, Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin—a mini-review, Life Sci., 113, 1, 10.1016/j.lfs.2014.07.029

Saha Roy, 2012, Role of estrogen receptor signaling in breast cancer metastasis, Int. J. Breast Cancer, 2012, 1, 10.1155/2012/654698

Sharma, 2018, Recent advances in metal nanoparticles in cancer therapy, J. Drug Target., 26, 617, 10.1080/1061186X.2017.1400553

Shen, 2016, Single dose oral and intravenous pharmacokinetics and tissue distribution of a novel hesperetin derivative MTBH in rats, Eur. J. Drug Metab. Pharmacokinet., 41, 675, 10.1007/s13318-015-0293-2

Sheokand, 2019, Nanocrystalline solid dispersions (NSD) of hesperetin (HRN) for prevention of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in Sprague-Dawley (SD) rats, Eur. J. Pharm. Sci., 128, 240, 10.1016/j.ejps.2018.12.006

Sulaiman, 2020, Hesperidin loaded on gold nanoparticles as a drug delivery system for a successful biocompatible, anti-cancer, anti-inflammatory and phagocytosis inducer model, Sci. Rep., 10, 9362, 10.1038/s41598-020-66419-6

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660

Tabeshpour, 2020, A review of the hepatoprotective effects of hesperidin, a flavanon glycoside in citrus fruits, against natural and chemical toxicities, Daru, 28, 305, 10.1007/s40199-020-00344-x

Tailby, 2017, Conservation surgery and radiation therapy in early breast cancer - An update, Aust. Fam. Physician, 46, 214

Tao, 2015, Breast cancer: epidemiology and etiology, Cell Biochem. Biophys., 72, 333, 10.1007/s12013-014-0459-6

Tilghman, 2013, Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness, Mol. Cell. Proteomics, 12, 2440, 10.1074/mcp.M112.023861

Tong, 2018, Recent advances in the treatment of breast cancer, Front. Oncol., 8, 227, 10.3389/fonc.2018.00227

Trivedi, 2011, Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat, Cardiovasc. Toxicol., 11, 215, 10.1007/s12012-011-9114-2

Waks, 2019, Breast cancer treatment: a review, J. Am. Med. Assoc., 321, 288, 10.1001/jama.2018.19323

Wang, 2019, Gluconeogenesis in cancer: function and regulation of PEPCK, FBPase, and G6Pase, Trends Cancer, 5, 30, 10.1016/j.trecan.2018.11.003

Wellberg, 2016, The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis, Breast Cancer Res., 18, 131, 10.1186/s13058-016-0795-0

Wilcox, 2001, Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP, J. Lipid Res., 42, 725, 10.1016/S0022-2275(20)31634-5

Wolfram, 2016, Hesperetin liposomes for cancer therapy, Curr. Drug Deliv., 13, 711, 10.2174/1567201812666151027142412

Wu, 2017, Nanomedicine applications in the treatment of breast cancer: current state of the art, Int. J. Nanomedicine, 12, 5879, 10.2147/IJN.S123437

Xiang, 2015, Doxorubicin resistance in breast cancer is driven by light at night induced disruption of the circadian melatonin signal, J. Pineal Res., 59, 60, 10.1111/jpi.12239

Xu, 2015, A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition, Cell Adhes. Migr., 9, 317, 10.1080/19336918.2015.1016686

Yan, 2020, Nanoparticle-based drug delivery system: a patient-friendly chemotherapy for oncology, Dose Response, 18, 10.1177/1559325820936161

Yang, 2014, Doxorubicin, DNA torsion, and chromatin dynamics, BBA, 1845, 84

Yang, 2013, Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells, Cell Biochem. Funct., 31, 374, 10.1002/cbf.2905

Ye, 2012, The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice, J. Nutr. Biochem., 23, 1230, 10.1016/j.jnutbio.2011.07.003

Yu, 2017, The glycolytic switch in tumors: how many players are involved?, J. Cancer, 8, 3430, 10.7150/jca.21125